BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20542034)

  • 1. Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers.
    Henson JD; Reddel RR
    FEBS Lett; 2010 Sep; 584(17):3800-11. PubMed ID: 20542034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomeres and telomerase in sarcomas.
    Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
    Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length maintenance--an ALTernative mechanism.
    Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE
    Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
    Nittis T; Guittat L; Stewart SA
    Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies.
    Jeyapalan JN; Mendez-Bermudez A; Zaffaroni N; Dubrova YE; Royle NJ
    Int J Cancer; 2008 Jun; 122(11):2414-21. PubMed ID: 18311780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
    Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
    J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
    Grach AA
    Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.
    Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR
    Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative lengthening of telomeres does exist in various canine sarcomas.
    Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
    Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative lengthening of telomeres in human cells.
    Reddel RR; Bryan TM; Colgin LM; Perrem KT; Yeager TR
    Radiat Res; 2001 Jan; 155(1 Pt 2):194-200. PubMed ID: 11121234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.
    LondoƱo-Vallejo JA; Der-Sarkissian H; Cazes L; Bacchetti S; Reddel RR
    Cancer Res; 2004 Apr; 64(7):2324-7. PubMed ID: 15059879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
    Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
    Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative lengthening of telomeres is induced by telomerase inhibitors in Barrett's esophageal cells.
    Qin X; Qi B; Zhao B
    Oncol Rep; 2013 Apr; 29(4):1399-404. PubMed ID: 23338150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
    Fasching CL; Bower K; Reddel RR
    Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative lengthening of telomeres, telomerase, and cancer.
    Reddel RR
    Cancer Lett; 2003 May; 194(2):155-62. PubMed ID: 12757973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
    Min J; Wright WE; Shay JW
    Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ALT--alternative lengthening of telomere].
    Wu XM; Tang WR; Luo Y
    Yi Chuan; 2009 Dec; 31(12):1185-91. PubMed ID: 20042385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
    Gocha ARS; Harris J; Groden J
    Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.